West Pharmaceutical Services, Inc. (NYSE:WST) Shares Bought by Blue Trust Inc.

Blue Trust Inc. raised its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WSTFree Report) by 238.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 819 shares of the medical instruments supplier’s stock after acquiring an additional 577 shares during the period. Blue Trust Inc.’s holdings in West Pharmaceutical Services were worth $270,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in the business. Net Worth Advisory Group acquired a new position in West Pharmaceutical Services during the third quarter valued at $623,000. Inspire Advisors LLC lifted its holdings in shares of West Pharmaceutical Services by 17.2% in the 3rd quarter. Inspire Advisors LLC now owns 1,618 shares of the medical instruments supplier’s stock valued at $486,000 after buying an additional 237 shares during the period. V Square Quantitative Management LLC boosted its stake in shares of West Pharmaceutical Services by 7.5% in the third quarter. V Square Quantitative Management LLC now owns 2,086 shares of the medical instruments supplier’s stock worth $626,000 after buying an additional 146 shares during the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd grew its holdings in West Pharmaceutical Services by 1.9% during the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 7,638 shares of the medical instruments supplier’s stock worth $2,293,000 after acquiring an additional 143 shares during the period. Finally, Trust Co. of Vermont purchased a new position in West Pharmaceutical Services during the third quarter valued at approximately $90,000. 93.90% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at West Pharmaceutical Services

In other news, VP Charles Witherspoon sold 1,029 shares of the stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $300.00, for a total transaction of $308,700.00. Following the sale, the vice president now directly owns 1,478 shares of the company’s stock, valued at $443,400. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.53% of the stock is owned by corporate insiders.

West Pharmaceutical Services Trading Up 15.4 %

Shares of NYSE:WST opened at $330.65 on Friday. The company has a current ratio of 2.34, a quick ratio of 1.68 and a debt-to-equity ratio of 0.03. West Pharmaceutical Services, Inc. has a 12-month low of $265.00 and a 12-month high of $413.70. The business has a 50 day moving average of $300.36 and a two-hundred day moving average of $322.86. The company has a market capitalization of $23.99 billion, a PE ratio of 47.03, a PEG ratio of 10.21 and a beta of 1.01.

West Pharmaceutical Services (NYSE:WSTGet Free Report) last posted its earnings results on Thursday, July 25th. The medical instruments supplier reported $1.52 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.74 by ($0.22). West Pharmaceutical Services had a net margin of 18.25% and a return on equity of 19.17%. The firm had revenue of $702.10 million during the quarter, compared to analyst estimates of $729.36 million. During the same quarter in the prior year, the firm earned $2.11 earnings per share. The business’s revenue for the quarter was down 6.9% on a year-over-year basis. As a group, analysts forecast that West Pharmaceutical Services, Inc. will post 6.42 EPS for the current year.

West Pharmaceutical Services Profile

(Free Report)

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.

See Also

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.